GNOM vs SPY
Global X Genomics & Biotechnology ETF vs State Street SPDR S&P 500 ETF Trust
Which is better, GNOM or SPY?
Mid Cap Growth against Large Cap Blend.
SPY has a lower expense ratio. GNOM led over 1Y, SPY over 3Y, 5Y and the full window. SPY is less concentrated, with 37.8% of the fund in its ten largest positions against 49.1%.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | GNOM | SPY |
|---|---|---|
| Expense Ratio | 0.50% | 0.09%Best |
| AUM | $92M | $804.7B |
| Dividend Yield | 1.01% | 0.98% |
| Holdings | 52 | 505 |
| YTD Return | +48.19%Best | +13.82% |
| 1Y Return | +79.95%Best | +16.96% |
| 3Y Return (annualized) | +19.05% | +22.97%Best |
| 5Y Return (annualized) | -6.16% | +13.73%Best |
| Volatility (annualized) | 30.2% | 16.6%Best |
| Max Drawdown | -75.0% | -34.1%Best |
| $10,000 over 5 years | $7,277 | $19,027Best |
| Top 10 Weight | 49.1% | 37.8%Best |
| Fund Family | Global X by mirae Asset | State Street Investment Management |
| Category | Equity | Equity |
| Style | Mid Cap Growth | Large Cap Blend |
| Inception | Apr 5, 2019 | Jan 22, 1993 |
Volatility and max drawdown are measured over the window both funds cover: Apr 10, 2019 to Sep 21, 2026 (7.4 years).
GNOM vs SPY growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 7.4 years both funds cover.
GNOM vs SPY Performance
Global X Genomics & Biotechnology ETF (GNOM) is an ETF from Global X by mirae Asset and State Street SPDR S&P 500 ETF Trust (SPY) is an ETF from State Street Investment Management. Over the past year GNOM returned +79.95% while SPY returned +16.96%. Year to date, GNOM is up 48.19% versus a gain of 13.82% for SPY.
Over three years, GNOM compounded at +19.05% per year against +22.97% for SPY; over five years the annualized figures are -6.16% and +13.73% respectively. Across the full 7-year window we track, SPY has the edge at +15.31% annualized vs +1.50%.
Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
GNOM has been the more volatile fund, with annualized monthly volatility of 30.2% compared with 16.6% for SPY. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -75.0% for GNOM and -34.1% for SPY. Drawdown depth is what each fund did in the worst stretch of the window measured above.
The two funds' monthly returns correlate at 0.62. They move together some of the time, and apart the rest.
Fees and Cost Over Time
GNOM charges 0.50% per year while SPY charges 0.09%. On a $10,000 position that is $50 vs $9 annually, a gap of $41 per year that compounds over a long holding period. On income, GNOM currently yields 1.01% against 0.98% for SPY.
Holdings Overlap
21.7% of GNOM's money is in holdings SPY also owns. 2.5% of SPY's money is in holdings GNOM also owns.
GNOM and SPY share little of their money.
9 positions in common, counted across the 50 positions we hold weights for in GNOM and 504 in SPY, against full books of 52 and 505.
What only one of them owns
Our book lists 488 positions for SPY that do not appear in our book for GNOM (96.8% of the fund), and 35 for GNOM that do not appear in SPY (62.0%).
Some of those will be the same company recorded under a different code in one of the two books, so the real difference in what you would own is no larger than this and may be smaller. We do not name the individual positions here for that reason.
Top Shared Holdings
| Stock | Weight in GNOM | Weight in SPY | Difference |
|---|---|---|---|
| MRNAModerna therapeutics | 8.20% | 0.08% | 8.12% |
| VRTXNvaesrtex Pharmaceuticals Inc | 3.70% | 0.21% | 3.49% |
| TECHBio-Techne Corp | 3.64% | 0.02% | 3.62% |
| LLYEli Lilly & Co. | 1.85% | 1.40% | 0.45% |
| GILDGilead Sciences | 1.67% | 0.28% | 1.39% |
| BMYBristol-Myers Squibb Co. | 1.03% | 0.21% | 0.82% |
| DHRDanaher Corporation | 1.01% | 0.20% | 0.81% |
| AAgilent Technologies Inc | 0.32% | 0.06% | 0.26% |
| DGXQuest Diagnostics Inc | 0.26% | 0.04% | 0.22% |
21.7% of GNOM is already inside SPY.
You probably hold more than these two. Add the rest and see how much of the whole book is the same companies twice.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, GNOM or SPY?
GNOM has an expense ratio of 0.50% while SPY charges 0.09%. SPY is the cheaper option, by $41 a year on a $10,000 investment.
Which performed better, GNOM or SPY?
Over the past year GNOM returned +79.95% vs +16.96% for SPY, so GNOM leads on 1-year performance. Over the longest common window we track (7 years), GNOM annualized +1.50% vs +15.31% for SPY. Past performance does not guarantee future results. This is information, not a recommendation.
Which is riskier, GNOM or SPY?
GNOM has been the more volatile fund at 30.2% annualized versus 16.6% for SPY. Worst drawdown: GNOM -75.0% vs SPY -34.1%.
Should I hold both GNOM and SPY?
GNOM and SPY have a monthly-return correlation of 0.62, so their returns are far enough apart for the mix to behave differently from either one alone. This is information, not a recommendation.
What is the holdings overlap between GNOM and SPY?
21.7% of GNOM's money is in holdings SPY also owns. 2.5% of SPY's is in holdings GNOM also owns. They hold 9 positions in common, counted across the 50 positions we hold weights for in GNOM and 504 in SPY.
Which pays a higher dividend, GNOM or SPY?
GNOM yields 1.01% while SPY yields 0.98%, so GNOM currently pays the higher dividend yield.
Is SPY better than GNOM?
SPY has a lower expense ratio. GNOM led over 1Y, SPY over 3Y, 5Y and the full window. SPY is less concentrated, with 37.8% of the fund in its ten largest positions against 49.1%. Which one suits a particular account depends on what it is for. This is information, not a recommendation.